Hebei Xingbai Pharmaceutical Group Co.
Hebei Xingbai Pharmaceutical Group is a privately held Chinese bio-manufacturer founded in 1987 that produces abamectin-based bio-pesticides, veterinary drugs, herbicides, and bio-fertilizers via proprietary corn-to-fermentation technology, selling through distributors in 30+ Chinese provinces and exporting to 200+ countries.
- Company typePrivate
- Founded1987
- HeadquartersShijiazhuang, China
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hebei Xingbai Pharmaceutical Group Co. does
Hebei Xingbai Pharmaceutical Group Co., Ltd. (河北兴柏药业集团有限公司) is a privately held Chinese bio-manufacturing and agrochemical group founded in 1987 and headquartered in Zhao County, Shijiazhuang, Hebei Province. The group operates 8 wholly-owned subsidiaries across bio-pesticides, agricultural technology, veterinary pharmaceuticals, biochemical engineering, vegetable oil processing, biological fertilizers, and biotechnology, employing 2,000+ people across a 1,500-acre industrial park with self-owned power generation and wastewater treatment. Its core technology is a proprietary corn-based bio-manufacturing platform that uses microbial fermentation to produce abamectin and related bio-pesticides, a process described as unique in China and recognized with the National Science and Technology Progress Award Second Class (2016/2017).
The group's commercial product portfolio spans technical-grade abamectin (92% purity), emamectin benzoate, neonicotinoid technical materials (dinotefuran, thiamethoxam), sulfonylurea herbicides (Danesilian/Danesuizhi developed with Nankai University), fungicide formulations, veterinary drug premixes (enramycin, monensin), bio-organic fertilizers, and pharmaceutical intermediates (long-chain dicarboxylic acids). Revenue is generated through direct manufacturer sales to a distributor network covering 30+ Chinese provinces and 2,000+ counties, alongside export to 200+ countries across Europe, America, Southeast Asia, Africa, the Middle East, and Latin America, supported by agronomist technical services and a multilingual corporate website. The subsidiary-level revenue of 2.151 billion CNY in 2022 (7.44% YoY growth) ranked it 33rd in the 2022 China Top 100 Pesticide Industry Sales ranking.
The company's value proposition rests on its vertically integrated corn-to-bio-pesticide value chain, deep R&D partnerships with Nankai University, China Agricultural University, Zhejiang University of Technology, and Huazhong Agricultural University, and an academician workstation led by Academician Li Zhengming. Certifications include ISO9001, ISO14001, ISO45001, and Ministry of Agriculture GMP for veterinary drugs, with the group recognized as a National Key Leading Enterprise in Agricultural Industrialization. The recent veterinary drug GMP certification for new non-sterile API and fermentation premix lines, alongside an India channel partnership with Indogulf Cropsciences, signals continued capacity scaling and international market access.
Hebei Xingbai Pharmaceutical Group Co. firmographics
Firmographics- Name
- Hebei Xingbai Pharmaceutical Group Co.
- Legal name
- Hebei Xingbai Pharmaceutical Group Co., Ltd. (河北兴柏药业集团有限公司)
- Website
- https://xingbai.cn
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Hebei Xingbai Pharmaceutical Group is a privately held Chinese bio-manufacturer founded in 1987 that produces abamectin-based bio-pesticides, veterinary drugs, herbicides, and bio-fertilizers via proprietary corn-to-fermentation technology, selling through distributors in 30+ Chinese provinces and exporting to 200+ countries.
- Ownership category
- akta.pro rank
Hebei Xingbai Pharmaceutical Group Co. industry classification
Industry- Product category
- Agrochemicals and Bio-pesticides
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (32532), Pesticide and Other Agricultural Chemical Manufacturing (325320)
- SIC
- Agricultural Chemicals (2870), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Commodity Surfactants & Detergent Base Chemicals (IMAEAAAI)
- akta.pro secondary industries
- Microbial Bioinsecticides (incl. Bt) (AFABAEAC), Insecticides (AFABAAAB), Biological Pest Control (Beneficial Insects, Nematodes, Microbials) (AFABAKAB)
Keywords
Where Hebei Xingbai Pharmaceutical Group Co. is headquartered
LocationHeadquarters
- HQ city
- Shijiazhuang
- HQ country
- China
- HQ region
- Asia
Offices4 records
Markets served
Hebei Xingbai Pharmaceutical Group Co. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pesticide Products Sales: Sales of abamectin technical, pesticide formulations, and related agrochemical products domestically and internationally. Main products include abamectin series, emamectin benzoate, and various pesticide formulations.
- Veterinary Drug Products: Production and sales of veterinary drugs including enramycin premix, monensin premix, and other animal health products
- Fertilizer Products: Sales of organic fertilizers, microbial agents, and biological fertilizers
- International Trade: Export of products to Europe, America, Southeast Asia and other international markets
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Direct sales to distributors with manufacturer pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Hebei Xingbai Pharmaceutical Group Co. product offering
Product offeringCore offering
Hebei Xingbai Pharmaceutical Group manufactures and sells bio-pesticides (primarily abamectin-based insecticides, acaricides, nematicides, and emamectin benzoate formulations), veterinary drugs (enramycin and monensin premixes), organic and microbial fertilizers, and pharmaceutical intermediates (long-chain dicarboxylic acids). The company uses proprietary corn-based microbial fermentation technology to produce technical grade active ingredients and downstream formulated end-use products for agricultural producers, distributors, and international agrochemical companies.
Product overview
Hebei Xingbai Pharmaceutical Group Co. operates as a diversified bio-pharmaceutical and agricultural technology company with a comprehensive portfolio spanning bio-pesticides (abamectin-based insecticides and nematicides, emamectin benzoate formulations), herbicide products (sulfonylurea herbicides including single danych sulfonamides developed with Nankai University), fungicides (噻呋酰胺-based products), veterinary drugs (feed additives like enramycin, monensin), bio-organic fertilizers (microbial inoculants, organic fertilizers), and pharmaceutical intermediates (long-chain dicarboxylic acids). The company produces both technical grade active ingredients and formulated end-use products, serving agricultural, veterinary, and pharmaceutical chemical markets. Core products include abamectin technical materials (92%), various abamectin formulations (suspension concentrates, emulsifiable concentrates, water-based emulsions, water dispersible granules), neonicotinoid insecticides (dinotefuran, thiamethoxam, imidacloprid), and novel pesticide compounds.
Differentiator
Problem solved
Functional benefit
Brands
- Baiwei (柏威): Brand name used for pesticide products such as 柏威霉素 10%阿维菌素悬浮剂 (Baiwei 10% Abamectin Suspension Concentrate).
- Aifu You (艾福由)
- Zhi Niao (鸷鸟)
- Shang Kuan (墒宽)
- Ying Yan (莺燕)
- Rui Bai (瑞柏)
- Jun Bai (骏柏)
- Zhu Er Feng (助尔丰)
- Xingbai Guyou (兴柏谷友)
- Shang Jin Lieren (赏金猎人)
- Xingbai Business School (兴柏商学院)
Products and services
- Abamectin (Avermectin) Technical and Formulated Products Core abamectin product line including 92% abamectin technical material, abamectin suspension concentrates (e.g., 10% abamectin SC), emulsifiable concentrates (1.8%, 3.2%, 5.0% EC), water-based emulsions (1.8%, 5.0% EW), and water dispersible granules. Produced using proprietary corn-based microbial fermentation. Used by agricultural distributors and farmers for insect, mite, and nematode control in crops.
- Emamectin Benzoate Technical and Formulated Products Emamectin benzoate product line including 95% technical material, 2.3% emulsifiable concentrate, and 5.7% water dispersible granules. Used for controlling lepidopteran pests in crops. Manufactured at the group's Shijiazhuang facility with 1,600 tons/year planned production capacity.
- Other Pesticide Technical Materials (Neonicotinoids and Novel Insecticides) Technical grade active ingredients including 98% dinotefuran, 98% thiamethoxam, 97% metaflumizone, 98% chlorfenapyr, 98% spirodiclofen, 98% bifenazate, 96% flonicamid, and 96% spirotetramat. Sold to downstream formulators and agrochemical companies for further formulation and distribution.
- Sulfonylurea Herbicides (Danesuizhi / Danesilian) Single sulfonylurea herbicide products developed jointly with Nankai University, including Danesuizhi (单嘧磺酯) and Danesilian (单嘧磺隆). Sold as 10% wettable powder for wheat field weed control with low dosage and environmental friendliness. Also includes 3% nicosulfuron oil dispersion suspension for post-emergence corn field weed control.
- Veterinary Drugs (Enramycin and Monensin Premixes) Animal feed additive premixes including enramycin premix and monensin premix, produced by subsidiary Shijiazhuang Hi-Co Animal Health Products Co., Ltd. with national Ministry of Agriculture GMP certification. Used by livestock and poultry farms, feed mills, and animal health distributors. Planned capacity of 1,000 tons/year monensin premix and 3,000 tons/year enramycin premix.
- Organic and Microbial Fertilizers Biofertilizer and organic fertilizer product line including microbial inoculants (有效活菌≥1亿/克, 中微量元素≥35%), 柏丰霉素 (Baifengmeisu) microbial biofertilizer, and 有机肥 organic fertilizer. Sold to agricultural producers for soil improvement and crop nutrition.
- Pharmaceutical Intermediates (Long-chain Dicarboxylic Acids) Long-chain dicarboxylic acids (DC12, DC13) produced as chemical intermediates for downstream use in fragrances, high-performance nylons, lubricants, coatings, and pharmaceuticals. Sold to industrial and pharmaceutical intermediate buyers.
- Branded Pesticide Formulations (Baiwei, Aifu You, Zhi Niao, Shang Kuan, Ying Yan, Ruibai, Junbai, Zhu'er Feng, Xingbai Guyou, Shangjin Lieren) Ten proprietary sub-brands of formulated pesticide products for crop protection, including abamectin SC, abamectin+spirodiclofen SC, antibiotic insecticide-acaricides, high-purity abamectin formulations, broad-spectrum formulations, spinosad biopesticide, green environmental-friendly biological pesticides, and sulfonylurea herbicide products. Sold through the distributor network and e-commerce platform to farmers across China.
Quantifiable outcome
- National Science and Technology Progress Award Second Class (2016/2017) for abamectin technology
- +2 more outcomes
Companies that use Hebei Xingbai Pharmaceutical Group Co.
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Hebei Xingbai Pharmaceutical Group Co. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hebei Xingbai Pharmaceutical Group Co. partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and major.
- Nankai University (南开大学)coreLong-term strategic partnership for herbicide development. Jointly developed innovative herbicides Danesilian (单嘧磺隆) and Danesuizhi (单嘧磺酯). Nankai University scientists including Academician Li Zhengming collaborate through academician workstation. Xingbai Group provides research funding and industrial implementation platform.
- China Agricultural University (中国农业大学)coreR&D partnership for bio-pesticide technology development. University provides scientific research support and technical expertise for abamectin production optimization.
- Zhejiang University of Technology (浙江工业大学)majorAcademician Zheng Yuguo from Zhejiang University of Technology visited group in 2023 for guidance and cooperation. Discussions on university-enterprise collaboration and research achievement implementation. Promotes innovation chain, industry chain, funding chain, and talent chain integration.
- Indogulf Cropsciences LimitedmajorIndian partner that obtained abamectin technical import license with Xingbai Group's support. Xingbai Group is the approved source for Indogulf's abamectin products in India. Partnership expands Xingbai's presence in the Indian market.
- Academician Li Zhengming (李正名院士)coreLeading scientist at Nankai University serving as chief scientist at Xingbai Group's academician workstation. Conducts research on sulfonylurea herbicides and abamectin derivatives. Group provides office space, research facilities and funding.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Hebei Xingbai Pharmaceutical Group Co. competitors and assessment
Company assessmentDirect peers
- Elanco Animal Health: Global animal health company with antibiotic feed additives (including monensin and enramycin adjacent products). Direct peer for Xingbai's animal health subsidiary targeting enramycin/monensin premix exports.
- Jiangsu Yangnong Chemical Co., Ltd. Major Chinese crop protection chemical manufacturer with extensive pyrethroid and insecticide portfolio. Competes with Xingbai in domestic distribution and international export markets for technical-grade pesticides.
- Zhejiang Hisun Pharmaceutical: Chinese pharmaceutical and chemical manufacturer with significant avermectin/ivermectin fermentation capacity. Closest direct peer to Xingbai on microbial bioinsecticide production technology and product range.
- Ningxia Qiyuan Pharmaceutical Co., Ltd. Chinese producer of bio-pesticides and veterinary pharmaceuticals with fermentation capabilities. Comparable to Xingbai in bio-fermentation manufacturing footprint and product mix spanning crop and animal health.
Emerging players
- PI Industries Limited: Indian agrochemical and custom research manufacturer with growing global presence in crop protection. Comparable emerging-market competitor to Xingbai, particularly relevant given shared Indian distribution interests via Indogulf.
- Bioceres Crop Solutions: Latin American agricultural biologicals company. Comparable as a peer focused on biologically derived crop inputs in emerging markets where Xingbai is building export presence.
Broad incumbents
- Corteva, Inc. Global seed and crop protection company with broad insecticide portfolio including spinosad and avermectin-class products. Competes with Xingbai in international markets and sets the technical benchmark for new active ingredient approvals.
- Syngenta Group: Global agrochemical leader (now China-owned) with broad insecticide, fungicide, and seed portfolio. Competes with Xingbai in both domestic China market and the export markets Xingbai targets.
- ADAMA Ltd. Global crop protection company with major presence in China, offering overlapping insecticide, acaricide and fungicide portfolios including abamectin-based products. Much larger scale incumbent in the same category Xingbai competes in.
- UPL Limited: India-headquartered global crop protection company with deep emerging-markets distribution. Relevant comparable as Xingbai's Indogulf partner targets the Indian market and UPL operates adjacent distribution channels.
Market position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Hebei Xingbai Pharmaceutical Group Co. social profiles
Digital presenceHebei Xingbai Pharmaceutical Group Co. compliance and trust
Trust signalCompliance5 records
Hebei Xingbai Pharmaceutical Group Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hebei Xingbai Pharmaceutical Group Co. leadership team
Management profileNumber of profiles
Profiles8 records
Hebei Xingbai Pharmaceutical Group Co. subsidiaries and ownership
Company hierarchySubsidiaries8 records
Hebei Xingbai Pharmaceutical Group Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hebei Xingbai Pharmaceutical Group Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hebei Xingbai Pharmaceutical Group Co.
What does Hebei Xingbai Pharmaceutical Group Co. do?
Hebei Xingbai Pharmaceutical Group manufactures and sells bio-pesticides (primarily abamectin-based insecticides, acaricides, nematicides, and emamectin benzoate formulations), veterinary drugs (enramycin and monensin premixes), organic and microbial fertilizers, and pharmaceutical intermediates (long-chain dicarboxylic acids). The company uses proprietary corn-based microbial fermentation technology to produce technical grade active ingredients and downstream formulated end-use products for agricultural producers, distributors, and international agrochemical companies.
Is Hebei Xingbai Pharmaceutical Group Co. a public or private company?
Hebei Xingbai Pharmaceutical Group Co. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hebei Xingbai Pharmaceutical Group Co. founded?
Hebei Xingbai Pharmaceutical Group Co. was founded in 1987. It employs 1,001 to 5,000 people.
Where is Hebei Xingbai Pharmaceutical Group Co. based?
Hebei Xingbai Pharmaceutical Group Co. is headquartered in Shijiazhuang, China, in the Asia region.
How does Hebei Xingbai Pharmaceutical Group Co. make money?
Four revenue lines are on record. Pesticide Products Sales are the primary driver. The others are veterinary Drug Products, fertilizer Products and international Trade.
Who are Hebei Xingbai Pharmaceutical Group Co.'s main competitors?
Direct peers on record are Elanco Animal Health, Jiangsu Yangnong Chemical Co., Ltd., Zhejiang Hisun Pharmaceutical and Ningxia Qiyuan Pharmaceutical Co., Ltd.. Emerging players are PI Industries Limited and Bioceres Crop Solutions. Broad incumbents are Corteva, Inc., Syngenta Group, ADAMA Ltd. and UPL Limited.
Does Hebei Xingbai Pharmaceutical Group Co. have an API?
No public API is recorded for Hebei Xingbai Pharmaceutical Group Co..
What industry is Hebei Xingbai Pharmaceutical Group Co. in?
Hebei Xingbai Pharmaceutical Group Co.'s product category is Agrochemicals and Bio-pesticides. Its primary akta.pro industry code is IMAEAAAI, Commodity Surfactants & Detergent Base Chemicals, with a secondary code of AFABAEAC, Microbial Bioinsecticides (incl. Bt). Its NAICS code is 32532 and its SIC code is 2870.